Today, the U.S. Food and Drug Administration permitted marketing of the Viz.AI Contact application, a type of clinical decision support software designed to analyze computed tomography (CT) results that may notify providers of a potential stroke in their patients.
Health and care service providers and users are increasingly facing complex decisions when exploring and investing in new health and care solutions. There is a need to support cross-border cooperation in preparation of procurement of research and innovative digital solutions, including on how to balance innovation risks with improved outcomes.
Abbott (NYSE: ABT) announced today the FreeStyle LibreLink app is now available in Europe for use with compatible smartphones(2) (both iPhone and Android). People with diabetes living in Europe and using the FreeStyle® Libre system(3) are now able to access glucose data directly from their smartphones, eliminating the need to carry the separate FreeStyle Libre reader(4) (a handheld device used to scan the FreeStyle Libre sensor to get a glucose result).
| Location: | Erlangen, Germany |
| Job Type: | Full-Time |
| Employer: | Siemens Healthineers™ |
European Commission has put forward a proposal to boost cooperation amongst EU Member States for assessing health technology. Greater transparency will empower patients, by ensuring their access to information on the added clinical value of new technology that could potentially benefit them.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced the launch of its next-generation Patient Monitoring solution in the U.S. The enterprise-wide system consists of bedside, transport, mobile and central station monitoring technology backed by a new approach to consulting, training, service and customer support, including a full range of product support and expert services.